The world is preparing for significant trade disruption. While protectionism is making a return and countries such as the United States are trying to strengthen their critical economic sectors, the retreat from free trade is accelerating under President Donald Trump – with far-reaching consequences, particularly for the fight against climate change.
By Marcel Grzanna
Washington sees Beijing as one of the main culprits for the USA's fentanyl problem. As a result, an additional ten percent import duty will apply to all Chinese exports to the country from Tuesday. China reacts with pique and recommends that the USA look for other solutions.
By Marcel Grzanna
The AI start-up DeepSeek is increasingly faced with accusations. Apart from massive data privacy loopholes, the AI company is now being criticized for a data leak. Italy has already taken action.
By Ning Wang
Conservative election frontrunner Friedrich Merz sees the American market as more of a "secure base" for German companies than China. Once again, the CDU/CSU candidate warns of major entrepreneurial risks and a lack of rule of law.
By Leonardo Pape
The Chinese government is working hard to boost domestic consumption. At least at the box office, revenues are picking up sharply. The Xinhua news agency is even talking about a milestone.
By Marcel Grzanna
With Chinese support, Tanzania and Burundi are building a 282-kilometer railroad line to transport metals such as nickel to the port of Dar es Salaam.
By Fabian Peltsch
The first provisions of the AI Act come into force on Feb. 2. In an interview with Corinna Visser, digital expert Kirsten Rulf from BCG explains how well-prepared German companies are, how to get to grips with the bureaucratic monster and why the narrative that the USA does not regulate AI is not true.
By Corinna Visser
Our "China Perspective" column is written by authors from the People's Republic. There have been heated discussions about China's healthcare system. The government has severely restricted access to branded foreign drugs in public hospitals. However, many doubt the effectiveness of domestic generic alternatives.
By Leonardo Pape
The Chinese EV manufacturer NIO started with ambitious plans in Germany. However, sales figures have drastically fallen short of expectations. Now, the manufacturer even appears to be ready to radically change its business model.
By Christian Domke Seidel
